Richard M Salib, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 Fax: 651-968-5904 |
Tyler R Williamson, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 16800 37th Pl N, Ste 200, Plymouth, MN 55446 Phone: 635-207-8707 Fax: 763-520-7580 |
Dr. Roman Gabriel Guerrero-maestre, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 |
Dr. Edward Rainier Gamboa Santos, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 Fax: 651-968-5904 |
Mr. Thomas F. Varecka, M.D. Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 2805 Campus Dr, Ste 425, Plymouth, MN 55441 Phone: 763-383-0770 Fax: 763-383-0777 |
Andrew Brooks, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 Fax: 651-968-5903 |
Jeffrey S Pinto, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 Fax: 651-968-5904 |
Mr. Michael Blake Jacob, PA-C Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 2855 Campus Dr, Plymouth, MN 55441 Phone: 763-577-7000 |
David Howard Strothman, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 150, Plymouth, MN 55446 Phone: 651-968-5201 Fax: 651-968-5904 |
News Archive
Like thousands of Americans, snoring keeps Dr. Kenny Pang awake at night. It's not his own nocturnal nasal sounds, or those of his wife, that trouble Dr. Pang - it's the why behind the sounds.
BD, a leading global medical technology company, today reported quarterly revenues of $2.014 billion for the third fiscal quarter ended June 30, 2011, representing an increase of 10.0 percent from the prior-year period.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
Low vitamin D status is a marker of ill health rather than an underlying cause of disease, say the authors of a systematic review published in The Lancet Diabetes and Endocrinology.
› Verified 9 days ago